Led · Equity · Mar 2026

Eco-inject has redesigned the single-use auto-injector to remove complexity and deliver significant carbon reductions at cost parity with existing devices. The company positions its device as scalable, low-carbon, and cost-effective, engineered from the ground up for high-volume production. Management framed the product as addressing the growing carbon footprint and manufacturing challenges driven by rising injectable treatments and rapid GLP‑1 uptake. Leadership includes CEO Matthew White working full-time alongside John Palmer‑Felgate, Michael Earl, Steven Kaufman and Richard Price. The company announced an oversubscribed £5.2 million funding round to take its product through to commercial production at scale. No revenue, user, or valuation metrics were disclosed in the available articles.

Participated · Equity · Sep 2025

NoBACZ Healthcare develops a patent-protected coating that forms an instant, flexible and waterproof barrier over animal wounds, replacing traditional antibiotics and cloth bandages. Applied as a gel, dip or spray, the coating seals out slurry and bacteria, enabling healing even in harsh farm environments and then biodegrades safely within the food chain. Large-scale validation includes a Flock Health trial on 6,840 lambs that showed lower mortality and higher market weights versus industry standards. The company is already selling in the UK, Ireland and mainland Europe, and is launching in New Zealand, the USA and Australia. Future plans include expanding its veterinary product pipeline and exploring human wound-care applications. The spin-out is led by co-founders Dr. Jonathan Powell (CEO) and Dr. Nuno Faria. The £4.8 million just raised will accelerate global distribution and finalize new products.

Led · Series A · Jul 2025

Modern Baker develops a nutrient-density platform and IP to make ultra-processed foods (UPFs) actively healthy without sacrificing taste or convenience. Its proof-of-concept product, SUPERLOAF, is manufactured by Hovis and is stocked in major UK retailers including M&S, Sainsbury’s and Ocado. The company works with university labs and has secured seven UK government grants to validate its science. Modern Baker operates a capital-light, SaaS-style model that licenses its technology to manufacturers so everyday brands can be upgraded. The pipeline targets multiple UPF categories — biscuits, sweet bakery, breakfast cereals, ready meals and beverages — beyond bread. Founded in 2017, the company positions nutrient density as a scalable fix for population health while enabling commercial growth.

Led · Seed · Apr 2025

Vizzy offers a platform for candidates to build personalised digital CVs and expressive profiles that showcase experience, interests, ambitions, and future potential. The product emphasizes visual storytelling, soft skills, and candidate motivation to help recruiters assess cultural fit and engagement beyond traditional résumés. Since launching its full product in 2023, Vizzy has been used by brands including Louis Vuitton, Virgin Group, PizzaExpress, Burberry, and WHSmith. The company targets early-career and high-volume hiring, aiming to surface diverse and non-traditional talent pools that are often missed by standard application processes. Vizzy plans to use its new funding to scale the platform globally and strengthen its product offering. The founders position the product as a solution to a labour market shaped by automation, mass applications, and Gen Z expectations.

Participated · Series A · Apr 2025

Limitless Travel offers fully supported, escorted holidays across the UK, Europe, and accessible cruises, with each trip designed to meet individual access needs. Holidays are led by experienced tour managers and supported by professional holiday companions who are qualified carers and can provide additional care where required. Since 2022 the company has delivered thousands of holidays and cruises, grown annual revenues by more than 350%, and expanded the team to over 80 staff. Founded in 2015 by Angus Drummond, the service draws on lived experience of disability in its design. The company intends to use new funding to expand its product range, enhance technology, and build a platform for global growth.